Qube Research & Technologies (QRT)
HCAT icon

Qube Research & Technologies (QRT)’s Health Catalyst HCAT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-282,281
Closed -$1.06M – 3734
2025
Q2 		$1.06M Buy
282,281
+114,626
+68% +$451K ﹤0.01% 2434
2025
Q1 		$759K Buy
167,655
+25,215
+18% +$133K ﹤0.01% 2379
2024
Q4 		$1.01M Buy
142,440
+48,888
+52% +$389K ﹤0.01% 2169
2024
Q3 		$762K Sell
93,552
-73,039
-44% -$528K ﹤0.01% 2130
2024
Q2 		$1.06M Buy
166,591
+86,218
+107% +$553K ﹤0.01% 1857
2024
Q1 		$605K Sell
80,373
-41,720
-34% -$381K ﹤0.01% 2431
2023
Q4 		$1.13M Buy
122,093
+51,248
+72% +$419K ﹤0.01% 1853
2023
Q3 		$717K Buy
+70,845
New +$846K ﹤0.01% 1872
2022
Q3 		– Sell
-74,697
Closed -$1.08M – 2702
2022
Q2 		$1.08M Buy
74,697
+23,211
+45% +$396K 0.01% 1069
2022
Q1 		$1.34M Buy
51,486
+46,182
+871% +$1.31M 0.01% 1013
2021
Q4 		$210K Sell
5,304
-1,986
-27% -$90.5K ﹤0.01% 1951
2021
Q3 		$365K Sell
7,290
-4,257
-37% -$232K ﹤0.01% 1392
2021
Q2 		$641K Buy
+11,547
New +$615K 0.01% 1151

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HCAT Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 282,281 shares — an estimated $1.06M sold.

Qube Research & Technologies (QRT) first reported a position in HCAT in Q2 2021 and held it in 13 quarters. The position peaked at $1.34M in Q1 2022. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 282,281 Health Catalyst shares in Q3 2025, an estimated $1.06M.
  • Qube Research & Technologies (QRT) first reported a position in Health Catalyst in Q2 2021 and held it in 13 quarters.
  • Qube Research & Technologies (QRT)'s Health Catalyst position peaked at $1.34M in Q1 2022.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.